India  

DCGI gives nod to Bharat Biotech to conduct phase I and II Human clinical trials to develop vaccine

Mid-Day Tuesday, 30 June 2020 ()
New Delhi: The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human clinical trials to develop an indigenous vaccine for COVID-19 -- in the name COVAXIN.

For this, Indian Council of Medical Research (ICMR) and BBIL had partnered to develop...
0
shares
ShareTweetSavePostSend
 
Video credit: Oneindia - Published
News video: Covid vaccine race| India puts 2 to human trials: Where do we stand? | Oneindia News

Covid vaccine race| India puts 2 to human trials: Where do we stand? | Oneindia News 02:34

India's Covaxin has entered clinical trials while the Drug controller Genral of India gave the nod for another vaccine by Zydus Cadila for phase I and II human trials. ICMR has asked Bharat Biotech to fast-track vaccine trials keeping a roll-out date of August 15th in mind. With 2 vaccines in the...

You Might Like


Related videos from verified sources

Covid vaccine race| India puts 2 to human trials: Where do we stand? |Oneindia News [Video]

Covid vaccine race| India puts 2 to human trials: Where do we stand? |Oneindia News

India's Covaxin has entered clinical trials while the Drug controller Genral of India gave the nod for another vaccine by Zydus Cadila for phase I and II human trials. ICMR has asked Bharat Biotech to..

Credit: Oneindia     Duration: 01:30Published
Covid vaccine in India by August 15? India to have a vaccine by Independence Day? | Oneindia News [Video]

Covid vaccine in India by August 15? India to have a vaccine by Independence Day? | Oneindia News

PM Modi is in Leh weeks after clashes in Galwan Valley, CDS Bipin Rawat and Army Chief MM Naravane accompany him; Over 20,000 Coronavirus cases in 24 hours for the first time in India; ICMR to launch..

Credit: Oneindia     Duration: 03:10Published
Coronavirus Vaccine: How Close Are We? [Video]

Coronavirus Vaccine: How Close Are We?

Researchers around the world are developing more than 145 vaccines against the coronavirus. 19 vaccines are in human trials but vaccines typically require years of research and testing. Scientists are..

Credit: Wochit News     Duration: 00:36Published

Related news from verified sources

Covid-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials

After Bharat Biotech's Covaxin, another potential Covid-19 vaccine indigenously developed by Ahmedabad-based Zydus Cadila Healthcare Ltd got the nod from the...
IndiaTimes Also reported by •HinduDNA

Tweets about this

Vimal20007751

NTR JR 💪 RT @ICMRDELHI: DCGI gives nod to Bharat Biotech to conduct phase I & II Human clinical trials to develop indigenous vaccine for COVID-19 ht… 40 minutes ago

ajitfrompuri

Ajit Ku. Mishra RT @otvnews: After Bharat Biotech's Covaxin, DGCI gives nod to India's second #Covid19 vaccine candidate which has been developed by Zydus… 1 hour ago

otvnews

OTV After Bharat Biotech's Covaxin, DGCI gives nod to India's second #Covid19 vaccine candidate which has been develope… https://t.co/bPFjw07srL 2 hours ago

Lokendra_98

Lokendra shekhawat RT @ani_digital: DCGI gives nod to Bharat Biotech to conduct phase I & II Human clinical trials to develop indigenous vaccine for COVID-19… 1 day ago